Abstract Library

#3459 Short-term tolerability and dose toxicity evaluation of 177Lu-DOTATATE for advanced neuroendocrine tumors (NET)

Introduction: 177Lu-DOTATATE has become a valuable treatment option in the management of advanced NET. However, PRRT treatment is usually limited by kidney toxicity, where the radiopharmaceutical is reabsorbed and retained, or bone marrow by evident hematological toxicity or in the liver.

Conference:

Presenting Author: Bonilla Plaza J

Authors: Bonilla Plaza J, Martinez Lorca A, Navarro Martinez T, Azpeitia Hernandez P, Alonso-Gordoa T,

Keywords: PRRT, 177Lu, Toxicity,

#2049 Identifying the Severity of Psychosocial Symptoms among Patients Diagnosed with Pancreatic Neuroendocrine Tumor. Do We Really Need Emotional Support Groups?

Introduction: Neuroendocrine tumors (pNETs) are the second most common neoplasm. Most of the pNETs are diagnosed at later stages among those patients who are underprivileged. The diagnosis and treatment of neuroendocrine tumor is a continuous emotional distress for both patient and their family.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Fatima A

Authors: Fatima A, Zai S,

Keywords: psychosocial symptoms, emotional support groups, neuroendocrine tumors,

#1682 Clinicohistopathological Features and Treatment Outcomes of Neuroendocrine Tumors; A Single Center Experience

Introduction: Neuroendocrine tumors (NETs) are very heterogeneous family of cancers.Tumor and patient characteristics of NETs significantly change between geographical locations that probably induced by environmental and genetic factors throughout the world. Therefore, reporting single center experience may help to clarify epidemiological view and to improve the decision-making process.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Sumbul A

Authors: Sumbul A, Sedef A, Kose F, Mertsoylu H, Sezer A,

Keywords: Neuroendocrine tumors, single center,

#188 Carcinoid

Introduction: There is a serious need to develop a clear framework based on multidisciplinary team practice, in order to facilitate early detection and management of carcinoid.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Derylo M, Daly B, Duffy E, Rita M,

Keywords: carcinoid, knowledge, nurse practitioners, diagnosis, symptoms, carcinoid questionnaire,

#57 Clinical and demographic characteristics in patients newly diagnosed with neuroendocrine tumors (NET)

Introduction: Neuroendocrine tumors (NETs) are tumors that form from cells that release hormones in response to a signal from the nervous system. These tumors may secrete higher-than-normal amounts of hormones, which can cause many different symptoms.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author:

Authors: Hess G, Hill J, Chen C, Quigley J, Liu Z,

Keywords: neuroendocrine tumors, clinical characteristics, demographic characteristics,